Genetic predisposition to invasive lobular carcinoma

Session:
#781
Date:
Thursday, Mar 7, 2019 6:00pm – 6:30pm
Authors:
Brandon Smith, Chunling Hu, Eric C. Polley, Fergus Couch, Holly Laduca, Jie Na, Jill Dolinsky, Siddhartha Yadav
Collaborators:
  • Despite accounting for about 15% of all BCs diagnosed each year, making ILC the second most common histologic subtype after invasive ductal breast cancer (IDC), it is largely underrepresented in genetic studies.
  • Pathogenic alteration frequencies were compared between female ILC and IDC cases, among ~91,000 patients referred for testing, including ~4700 ILC cases
  • Pathogenic alterations were more common in CDH1 in ILC patients while BRCA1 and PALB2 were more common in IDC patients. Other than that, gene-specific pathogenic alterations were similar between ILC and IDC cases referred for MGPT, supporting multigene panel testing when suspecting hereditary cancer predisposition regardless of an ILC vs. IDC diagnosis.